Global Plasma Fractionation Market

Global Plasma Fractionation Market Size, Share, Growth Analysis, By Product(Albumin, Immunoglobulins), By Method(Centrifugation, Depth Filtration), By Application(Neurology, Hematology), By End Use(Hospitals & Clinics, Clinical Research and Others) - Industry Forecast 2024-2031

Report ID: SQMIG35H2165 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 119 | Figures: 77

Global Plasma Fractionation Market News

  • In February 2024, at the GC Biopharma Ochang Plant in South Korea, workers wearing white uniforms were seen through a window. They were carefully labeling containers filled with orange liquid, called plasma, in the plasma storage inspection room. 
  • In October 2023, SK Plasma from South Korea announced that it had signed a term sheet with Indonesia Investment Authority (INA), a government-owned sovereign wealth fund. This agreement outlines the basic terms and conditions for investing in the construction of a blood product plant in Indonesia. 
  • In August 2023, Cambodian conglomerate Royal Group of Companies (RGC) partnered with two Australian firms to establish a joint venture (JV). The aim is to collect plasma across Asia and construct a new plasma fractionation facility in Singapore. The facility, costing $400 million, is intended to fractionate one million liters of plasma annually.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Plasma Fractionation Market size was valued at around USD 30.87 billion in 2022 and is expected to rise from USD 33.43 billion in 2023 to reach a value of USD 63.27 billion by 2031, at a CAGR of 8.3% over the forecast period (2024–2031).

To improve their market position, key companies in this market are using a variety of strategies, such as alliances through mergers and acquisitions, geographic expansion, and strategic collaborations. For instance, Terumo Blood and Cell Technologies debuted its most recent production plant in May 2022 in Douglas County, Colorado. The modern production plant, which cost USD $250 million, is in line with the company's goals of improving society via healthcare and serving more people. The 170,000 square foot facility will provide one-time use collection sets for the recently FDA authorized Rika Plasma Donation System, which will give clients (Rika) access to source plasma collections. 'CSL Behring', 'Grifols', 'Octapharma', 'Baxalta/Shire', 'Kedrion', 'China Biologic Products Holdings', 'Sanquin', 'Bio Products Laboratory', 'Japan Blood Products Organization', 'LFB Group', 'Shanghai RAAS Blood Products', 'Green Cross Corporation', 'Baxter International Inc.', 'Takeda Pharmaceutical Company Limited', 'Beijing Tiantan Biological Products', 'Biotest AG', 'China National Pharmaceutical Group Co. (Sinopharm)', 'GC Pharma', 'ADMA Biologics', 'Emergent BioSolutions'

The aging population is another major driver of the plasma fractionation market. As people age, they are more likely to develop chronic diseases and require medical treatments, including plasma-derived products.

Growing Demand for Immunoglobulins: The demand for immunoglobulins is increasing due to their use in the treatment of immune deficiencies and autoimmune diseases. As a result, there has been a significant increase in the production and use of immunoglobulins, which is driving market growth.

North America has a 53.93% share of the regional market, dominating it. This is a result of both an increase in the prevalence of respiratory illnesses and growing knowledge of the many benefits of plasma among North American citizens. The expansion of the regional market is further aided by the existence of key players, an increase in the quantity of plasma collection facilities, a rise in the consumption of plasma collections and distribution of immunoglobulin, and the availability of plasma.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Plasma Fractionation Market

Report ID: SQMIG35H2149 | Region: Global | Published Date: April, 2024 | Pages: 198 | Tables: 91 | Figures: 76

Global Protein Chip Market
Buy Now GET FREE SAMPLE
Global Plasma Fractionation Market

Report ID: UCMIG35H2178 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Biologics Contract Development Market
Buy Now GET FREE SAMPLE
Global Plasma Fractionation Market

Report ID: UCMIG35H2230 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Synthetic Biosensors Market
Buy Now GET FREE SAMPLE
Global Plasma Fractionation Market

Report ID: SQMIG35H2058 | Region: Global | Published Date: April, 2024 | Pages: 219 | Tables: 99 | Figures: 67

Global Biopharmaceuticals Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Plasma Fractionation Market

Product ID: SQMIG35H2165

$5,300
BUY NOW GET FREE SAMPLE